GB9703633D0 - Cancer therapy - Google Patents

Cancer therapy

Info

Publication number
GB9703633D0
GB9703633D0 GBGB9703633.9A GB9703633A GB9703633D0 GB 9703633 D0 GB9703633 D0 GB 9703633D0 GB 9703633 A GB9703633 A GB 9703633A GB 9703633 D0 GB9703633 D0 GB 9703633D0
Authority
GB
United Kingdom
Prior art keywords
cancer therapy
cancer
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9703633.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Horizons Ltd
Original Assignee
Imperial Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Cancer Research Technology Ltd filed Critical Imperial Cancer Research Technology Ltd
Priority to GBGB9703633.9A priority Critical patent/GB9703633D0/en
Publication of GB9703633D0 publication Critical patent/GB9703633D0/en
Priority to PCT/GB1998/000551 priority patent/WO1998037207A1/en
Priority to AU63007/98A priority patent/AU6300798A/en
Pending legal-status Critical Current

Links

GBGB9703633.9A 1997-02-21 1997-02-21 Cancer therapy Pending GB9703633D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9703633.9A GB9703633D0 (en) 1997-02-21 1997-02-21 Cancer therapy
PCT/GB1998/000551 WO1998037207A1 (en) 1997-02-21 1998-02-20 Antitumor genetic constructs
AU63007/98A AU6300798A (en) 1997-02-21 1998-02-20 Antitumor genetic constructs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9703633.9A GB9703633D0 (en) 1997-02-21 1997-02-21 Cancer therapy

Publications (1)

Publication Number Publication Date
GB9703633D0 true GB9703633D0 (en) 1997-04-09

Family

ID=10808080

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9703633.9A Pending GB9703633D0 (en) 1997-02-21 1997-02-21 Cancer therapy

Country Status (3)

Country Link
AU (1) AU6300798A (en)
GB (1) GB9703633D0 (en)
WO (1) WO1998037207A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795414B1 (en) * 1999-06-22 2002-07-05 Ass Pour Le Dev De La Rech En POLYPEPTIDE ICBP90 AND ITS FRAGMENTS AND POLYNUCLEOTIDES ENCODING SAID POLYPEPTIDES AND APPLICATIONS TO THE DIAGNOSIS AND TREATMENT OF CANCER
GB0215496D0 (en) * 2002-07-04 2002-08-14 Imp College Innovations Ltd Screening for anti-ovulatory compounds
NZ538284A (en) 2002-07-18 2008-04-30 Helix Biopharma Corp Use of urease and targeting molecule for inhibiting cancer cell growth
US7264800B2 (en) 2002-07-18 2007-09-04 Helix Biopharma Corporation Method and composition for inhibiting cancer cell growth
US7816131B2 (en) 2004-04-02 2010-10-19 Board Of Regents, The University Of Texas System Cancer specific promoters
WO2016141480A1 (en) * 2015-03-09 2016-09-15 Mount Sinai Hospital Tools and methods for using cell division loci to control proliferation of cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616685D0 (en) * 1995-10-02 1996-09-25 Cancer Res Campaign Tech Antitumour vector constructs and methods

Also Published As

Publication number Publication date
WO1998037207A1 (en) 1998-08-27
AU6300798A (en) 1998-09-09

Similar Documents

Publication Publication Date Title
EG24678A (en) Combination therapy
IL127306A0 (en) Combination therapy
ZA982368B (en) New therapeutic combinations
GB9700939D0 (en) Therapy
GB9816556D0 (en) Therapy
GB9509572D0 (en) Cancer therapy
AU1710600A (en) Enhanced radiation therapy
GB9703633D0 (en) Cancer therapy
GB9308166D0 (en) Cancer therapy
GB9723999D0 (en) Therapeutic use
GB9726701D0 (en) Therapeutic use
GB9804361D0 (en) Cancer treatment
IL120901A0 (en) Cancer therapy
GB9701876D0 (en) Cancer therapy
GB9806039D0 (en) Therapy
GB9727347D0 (en) Cancer
GB9704885D0 (en) Therapy
GB9726702D0 (en) Therapeutic use
GB9716289D0 (en) Tumour treatment
GB9708190D0 (en) Cancer marker
GB9605525D0 (en) Therapy
GB9605466D0 (en) Therapy
GB9424578D0 (en) Cancer treatment
ZA987632B (en) Cholesterol-lowering therapy
GB9818023D0 (en) Cancer treatment